Subscribe to RSS - Vertess


Buyers gonna buy, but with later payouts


FORT WORTH, Texas - Despite the challenges of 2020 and the havoc the COVID-19 pandemic has brought to bear on the economy, Brad Smith is bullish on the M&A market for HME. Vertess closed on four deals in the second and third quarters, and is teed up for an even busier Q4 and beyond.

Vertess closes four deals during pandemic


FORTH WORTH, Texas – Vertess has closed on four DME transactions in the second and third quarters, despite the challenges brought on by the COVID-19 pandemic.

Pandemic speeds up consolidation

But deals are taking longer to close, analysts say

YARMOUTH, Maine – After briefly hitting the pause button in March when “the world turned upside down,” buyers and sellers are back at the table, say M&A analysts.

COVID-19 and HME M&A

Thursday, May 14, 2020

I caught up with Brad Smith, managing director and partner at Vertess, recently and he said the mergers and acquisition market for HME has been “a wild rollercoaster ride” amid the coronavirus pandemic.

In brief: Invacare improves adjusted EBITDA, Option Care Health sees ‘robust’ growth


ELYRIA, Ohio – Invacare reported net sales of $218.4 million in the first quarter, a 2.2% decrease compared to the same period last year.

Vertess makes new hire


FORT WORTH, Texas – Vertess has added Matt Moebius to its business development team. Moebius brings a long history of HME experience in all aspects of the business from sales and operations to logistics and business development.

Vertess taps new managing director


FORT WORTH, Texas – Vertess has hired Chris Nielson as a managing director. Neil, formerly a managing partner at Four Capital, is an experienced advisor in the durable medical equipment and home health space.

M&A predictions: Active start, followed by uncertainty


YARMOUTH, Maine – Building on a handful of notable deals in late 2019, M&A analysts say they expect a strong 2020—at least to start.

Reporter’s notebook: When Adapt goes public, industry will be watching


PLYMOUTH MEETING, Pa. ­–­ When AdaptHealth goes public later this year, other large players in the industry may consider doing the same, says Brad Smith, managing director/partner at Vertess.

The implications of AdaptHealth’s upcoming IPO

Tuesday, October 1, 2019
Following Adapt going public, will private equity-backed DME providers line up at the NASDAQ, eager to cash in their chips?

When AdaptHealth's plan to become a public company was announced in July, ears perked up throughout the HME industry. New IPO listings by DME providers are rare. That could change following Adapt’s IPO.